Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN114539198B reveals novel Pd-catalyzed route for amide synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed thiocarbonylation for (iso)chroman thioesters. Avoids thiols, uses sulfonyl chlorides. Cost-effective pharma intermediate manufacturing.
Patent CN103992225B reveals novel salicylaldehyde synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing globally.
Patent CN111848322B details a novel chiral phosphoric acid catalyzed resolution for axially chiral oxindole styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediates.
Patent CN112125843B reveals a metal-free Oxone-mediated route for high-purity pharmaceutical intermediates, offering significant cost reduction and supply chain reliability.
Advanced patent CN103304550B details high-yield Olmesartan Medoxomil synthesis. Delivers supply chain stability and cost efficiency for global pharmaceutical manufacturers.
Patented iodine-catalyzed selenization offers high yields and metal-free conditions for scalable pharmaceutical intermediate manufacturing and cost-effective supply chains.
Patent CN112209947A details a mild, high-yield synthesis of chiral indoxazinones with potent anti-tumor activity, offering reliable supply chain solutions.
Patent CN117486772A reveals metal free synthesis enabling cost reduction in fine chemical manufacturing and high purity organoselenium compounds for scalable production.
Novel nickel-catalyzed method offers cost reduction in pharma intermediates manufacturing with scalable one-pot synthesis for high-purity aryl alkenyl sulfoxide.
Patent CN116514621B reveals metal-catalyzed Sommelet-Hauser rearrangement using sulfur ylides. This method offers safe scalable synthesis for pharmaceutical intermediates reducing hazardous diazo compound reliance significantly.
Patent CN112479993A details a cost-effective iron-catalyzed synthesis for KRAS inhibitor intermediates, offering significant supply chain and purity advantages for API manufacturers.
Novel iodine-promoted synthesis of 5-CF3-1,2,4-triazoles. Metal-free, scalable route for API intermediates offering significant cost reduction.
Patent CN105175327B reveals AgOTf catalyzed quinoline synthesis offering high purity and cost reduction in pharmaceutical intermediate manufacturing for global supply chains.
Patent CN101792438A details a copper-catalyzed decarboxylative coupling for high-purity triazole intermediates, offering cost-effective manufacturing solutions.
Patent CN110117237B reveals a mild nickel-catalyzed cyanation method for aromatic nitriles. This technology offers significant cost reduction and supply chain reliability for fine chemical manufacturing.
Patent CN110683926B reveals a robust Pd-catalyzed method for direct C-O coupling, offering high yields and broad substrate scope for reliable pharmaceutical intermediate manufacturing.
Patent CN107602452B reveals a one-pot copper-catalyzed method for 3-acyl pyridines, offering cost reduction in API manufacturing and reliable supply chain solutions.
Novel Mo/Cu co-catalyzed method for high-purity triazole intermediates. Reduces steps and costs for API manufacturing with mild conditions.
Novel copper-catalyzed route for high-purity quinazolinone intermediates. Enhanced yield and fluorescence sensing applications for industrial procurement and supply chain stability.